Literature DB >> 14741750

Does drug abuse beget drug abuse? Behavioral analysis of addiction liability in animal models of prenatal drug exposure.

C J Malanga1, Barry E Kosofsky.   

Abstract

Prenatal exposure to drugs of abuse is the single largest preventable cause of developmental compromise of American children today. In the clinical population, it is difficult to determine the independent effects of gestational exposure to a single drug on brain development, in part due to the confounding effects of additional risk factors that are encountered in the substance-abusing population. The enormous clinical and societal problem of gestational toxicity of drugs of abuse, both legal and illegal, has driven the need to develop and investigate animal models of gestational drug exposure in which these variables can be controlled. More specifically, as clinical data are gathered suggesting an increased liability to substance abuse among children of drug-abusing mothers, a mechanistic understanding of the lasting effects of early drug exposure on the developing brain and the behavioral repertoire of the developing animal is crucial. In this review we summarize experimental animal research that investigates the role of drug exposure in utero on the functional development of specific brain circuits that are involved in the reinforcing effects of drugs of abuse, and on the behaviors that are mediated by these brain reward systems.

Entities:  

Mesh:

Year:  2003        PMID: 14741750     DOI: 10.1016/j.devbrainres.2003.09.019

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  34 in total

1.  Early adolescent cocaine use as determined by hair analysis in a prenatal cocaine exposure cohort.

Authors:  Tamara Duckworth Warner; Marylou Behnke; Fonda Davis Eyler; Nancy J Szabo
Journal:  Neurotoxicol Teratol       Date:  2010-07-18       Impact factor: 3.763

Review 2.  Striatal morphological and functional alterations induced by prenatal alcohol exposure.

Authors:  Yao-Ying Ma
Journal:  Pharmacol Res       Date:  2019-02-23       Impact factor: 7.658

3.  Prenatal exposure to cocaine alters the development of conditioned place-preference to cocaine in adult mice.

Authors:  C J Malanga; Martina Pejchal; Barry E Kosofsky
Journal:  Pharmacol Biochem Behav       Date:  2007-06-21       Impact factor: 3.533

Review 4.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

5.  Prenatal Ethanol Exposure and Postnatal Environmental Intervention Alter Dopaminergic Neuron and Microglia Morphology in the Ventral Tegmental Area During Adulthood.

Authors:  Claudia I Aghaie; Kathryn A Hausknecht; Ruixiang Wang; Parisa Halaji Dezfuli; Samir Haj-Dahmane; Cynthia J M Kane; Wade J Sigurdson; Roh-Yu Shen
Journal:  Alcohol Clin Exp Res       Date:  2020-01-25       Impact factor: 3.455

6.  Effects of prenatal cocaine/polydrug exposure on substance use by age 15.

Authors:  Sonia Minnes; Lynn Singer; Meeyoung O Min; Miaoping Wu; Adelaide Lang; Susan Yoon
Journal:  Drug Alcohol Depend       Date:  2013-10-09       Impact factor: 4.492

Review 7.  Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder.

Authors:  Verónica Pastor; Marta Cristina Antonelli; María Eugenia Pallarés
Journal:  Neurotox Res       Date:  2016-10-24       Impact factor: 3.911

Review 8.  Transcriptional and epigenetic mechanisms of addiction.

Authors:  Alfred J Robison; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2011-10-12       Impact factor: 34.870

9.  Effects of prenatal alcohol and cigarette exposure on offspring substance use in multiplex, alcohol-dependent families.

Authors:  Jessica W O'Brien; Shirley Y Hill
Journal:  Alcohol Clin Exp Res       Date:  2014-12       Impact factor: 3.455

10.  Neuropathological consequences of prenatal cocaine exposure in the mouse.

Authors:  Jia-Qian Ren; C J Malanga; Eddy Tabit; Barry E Kosofsky
Journal:  Int J Dev Neurosci       Date:  2004 Aug-Oct       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.